Acadia Pharma (ACAD) Misses Q4 EPS by 2c
Tweet
Share
E-mailGet Alerts ACAD Hot Sheet
Price: $25.97 +3.06%
EPS Growth %: -62.5%
Financial Fact:
Loss from operations: -72.4M
Today's EPS Names:
PKE, LNN, More
EPS Growth %: -62.5%
Financial Fact:
Loss from operations: -72.4M
Today's EPS Names:
PKE, LNN, More
Join SI Premium – FREE
Acadia Pharma (NASDAQ: ACAD) reported Q4 EPS of ($0.28), $0.02 worse than the analyst estimate of ($0.26).
For earnings history and earnings-related data on Acadia Pharma (ACAD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump said he was unaware of his earnings from crypto
- Lockheed Martin frontrunner for $3.5B Ultra Maritime deal, sources say - FT
- Blue Owl keeps 5% redemption caps as OCIC requests ease from prior quarter
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
